MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Stryker Corporation Total Assets 2011-2026 | SYK
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.8 B | 43 B | 39.9 B | 36.9 B | 34.6 B | 34.3 B | 30.2 B | 27.2 B | 22.2 B | 20.4 B | 16.2 B | 17.7 B | 15.7 B | 13.2 B | 12.4 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47.8 B | 12.4 B | 27.5 B |
Quarterly Total Assets Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.1 B | 46.3 B | 46 B | 43.8 B | 39.1 B | 39.4 B | 38 B | 37.4 B | 36.8 B | 36.9 B | 36 B | - | 36.1 B | 34.6 B | 34.1 B | 33.7 B | 33.5 B | 34.3 B | 34.3 B | 34.3 B | 34.3 B | 30.2 B | 30.2 B | 30.2 B | 30.2 B | 27.2 B | 27.2 B | 27.2 B | 27.2 B | 22.2 B | 22.2 B | 22.2 B | 22.2 B | 20.4 B | 20.4 B | 20.4 B | 20.4 B | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 17.3 B | 17.7 B | 17.7 B | 17.7 B | 15.4 B | 15.7 B | 15.7 B | 15.7 B | 13.2 B | 13.2 B | 13.2 B | 13.2 B | 12.1 B | 12.4 B | 12.4 B | 12.4 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.1 B | 12.1 B | 26 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Bruker Corporation
BRKR
|
5.81 B | $ 36.74 | - | $ 5.47 K |  USA |
 |
ClearPoint Neuro
CLPT
|
97.7 M | $ 9.38 | - | $ 266 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cytosorbents Corporation
CTSO
|
44.2 M | $ 0.59 | - | $ 36.7 M | USA |
 |
AdaptHealth Corp.
AHCO
|
4.32 B | $ 12.07 | - | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Delcath Systems
DCTH
|
124 M | $ 9.7 | - | $ 347 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.5 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
13.7 B | $ 81.19 | - | $ 47.5 B | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.6 | - | $ 122 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 88.6 | - | $ 12 B | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.9 | - | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 9.31 | - | $ 717 M | USA |
 |
Inspire Medical Systems
INSP
|
907 M | $ 54.14 | - | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
29.2 M | $ 1.0 | - | $ 16.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.41 B | $ 85.63 | - | $ 2.97 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
509 M | $ 15.94 | - | $ 374 M | USA |
 |
LENSAR
LNSR
|
71.4 M | $ 5.89 | -2.81 % | $ 70.4 M | USA |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Medtronic PLC
MDT
|
91.7 B | $ 86.28 | - | $ 111 B | USA |
 |
Align Technology
ALGN
|
6.21 B | $ 171.87 | - | $ 12.9 B | USA |
 |
Myomo
MYO
|
38.6 M | $ 0.7 | - | $ 29.3 M | USA |
 |
AxoGen
AXGN
|
222 M | $ 32.64 | - | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Orthofix Medical
OFIX
|
851 M | $ 11.77 | - | $ 466 M |  Curacao |
 |
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Penumbra
PEN
|
1.83 B | $ 329.87 | - | $ 12.8 B | USA |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
Insulet Corporation
PODD
|
3.19 B | $ 203.5 | - | $ 14.3 B | USA |
 |
Sintx Technologies
SINT
|
9.51 M | $ 2.53 | 0.4 % | $ 7.02 M | USA |
 |
Butterfly Network
BFLY
|
256 M | $ 4.13 | -0.24 % | $ 874 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Smith & Nephew plc
SNN
|
10.5 B | $ 32.63 | - | $ 23.8 B |  Britain |
 |
Tactile Systems Technology
TCMD
|
274 M | $ 24.57 | - | $ 562 M | USA |
 |
TELA Bio
TELA
|
81.4 M | $ 0.63 | 5.47 % | $ 29.6 M | USA |
 |
TransMedics Group
TMDX
|
1.07 B | $ 104.8 | - | $ 3.56 B | USA |
 |
Tandem Diabetes Care
TNDM
|
881 M | $ 19.17 | - | $ 1.3 B | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
BioSig Technologies
BSGM
|
188 M | - | 37.08 % | $ 85.7 M | USA |